SCHEMBL28072124

SCHEMBL28072124

NCc1ccc(S(=O)(=O)NC(=O)c2ccc(N3CCN(Cc4ccccc4-c4ccc(Cl)cc4)CC3)cc2Oc2ccccc2)cc1

nearest known ligand 0.84

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 1/20 0.68
▸ BCL2L1 Q07817 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2996436 0.93 BCL2 (0.74) BCL2BCL2L1
SCHEMBL1744765 0.91 BCL2 (0.69) BCL2BCL2L1
SCHEMBL1958426 0.91 BCL2 (0.73) BCL2BCL2L1
SCHEMBL1958254 0.91 BCL2 (0.71) BCL2BCL2L1
SCHEMBL1742960 0.89 BCL2 (0.72) BCL2
SCHEMBL1743343 0.89 BCL2 (0.70) BCL2BCL2L1
SCHEMBL1955509 0.88 BCL2 (0.65) BCL2BCL2L1
SCHEMBL1743317 0.88 BCL2 (0.73) BCL2
SCHEMBL1954940 0.86 BCL2 (0.65) BCL2BCL2L1
SCHEMBL19424916 0.86 BCL2 (0.67) BCL2BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102307872-B BCL-2-selectively apoptosis-inducing agents for the treatment of cancer and immune diseases ABBVIE 公司 2016-06-15 — — CN disclosed
Send feedback